Baxter International stock trades steady as spin-off of kidney care business and margin focus shape

{
  "signal_id": "5917725b-e626-3514-858b-af4aa441cabc",
  "signal_type": "news",
  "signal_subtype": "has_revenue",
  "detected_at": "2026-07-19T11:19:36+00:00",
  "company": {
    "name": "Baxter",
    "domain": "baxter.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/baxter-international-stock-trades-steady-as-spin-off-of-kidney-care/69804040",
    "title": "Baxter International stock trades steady as spin-off of kidney care business and margin focus shape - ad-hoc-news.de",
    "excerpt": "Baxter International stock reflects a healthcare company in mid-transformation, with investors closely watching margins and portfolio moves after a recent spin-off of its kidney care business. Baxter International Inc. (ISIN US0673431090) reported full-year 2023 revenue of around $14.9 billion, with operating performance uneven across segments and a renewed focus on streamlining its portfolio and strengthening profitability. In early 2024, the group continued to adjust its structure, including completing the separation of its kidney care activities into a standalone company, while reporting a first-quarter 2024 revenue figure in the low-single-digit billions of dollars that provided a reference point for its ongoing turnaround efforts. For the 2023 financial year, Baxter International reported total revenue of approximately $14.9 billion, broadly stable compared with 2022 and highlighting the scale of its diversified medical products portfolio. The company disclosed that one major segment, focused on hospital-related products and therapies, contributed several billion dollars of this total, while other segments such as pharmaceuticals and renal care also accounted for substantial portions of group sales. Despite this revenue base, Baxter posted diluted earnings per share from continuing operations that reflected restructuring charges, product rationalizations, and costs...",
    "summary": "Baxter International Inc. reported total revenue of approximately $14.9 billion for the 2023 financial year.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2699596_1920_1080.webp",
    "confidence": 0.9,
    "published_at": "2026-07-19T11:19:36Z",
    "article_sentence": "For the 2023 financial year, Baxter International reported total revenue of approximately $14.9 billion, broadly stable compared with 2022 and highlighting the scale of its diversified medical products portfolio.",
    "amount_normalized": 14900000000
  }
}

curl https://signals.autobound.ai/v1/signals/5917725b-e626-3514-858b-af4aa441cabc \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"baxter.com","limit":20}'